US equities
|
SPCX
$144.75
▼-9.14%
MU
$856.49
▼-6.26%
NVDA
$212.21
▼-4.40%
META
$648.85
▼-6.98%
TSLA
$374.58
▼-3.08%
AAPL
$348.22
▲+1.23%
AMD
$507.93
▼-8.10%
SNDK
$1,260.93
▼-8.51%
SPCX
$144.75
▼-9.14%
MU
$856.49
▼-6.26%
NVDA
$212.21
▼-4.40%
META
$648.85
▼-6.98%
TSLA
$374.58
▼-3.08%
AAPL
$348.22
▲+1.23%
AMD
$507.93
▼-8.10%
SNDK
$1,260.93
▼-8.51%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Roxadustat
Recent news which mentions Roxadustat
FibroGen Analyst Removes Roxadustat Sales From Model After AdCom Snub
July 16, 2021
Tickers
FGEN
Tags
Jason Gerberry
Analyst Color
BofA Securities
From
Benzinga
What 3 FibroGen Analysts Are Expecting From Thursday's Roxadustat Adcom Verdict
July 14, 2021
Tickers
AZN
FGEN
Tags
Benzinga
Biotech
AZN
From
Benzinga